Advanced glycation end products induce a prothrombotic phenotype in mice via interaction with platelet CD36

Platelet CD36 surface expression levels affect functional responses to oxidized LDL and are associated with inheritance of specific genetic polymorphisms

(2011) A. Ghosh et al.   BLOOD

Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients

(2011) A. Carobbio et al.   BLOOD

Vav guanine nucleotide exchange factors link hyperlipidemia and a prothrombotic state

(2011) K. Chen et al.   BLOOD

Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome

(2011) José Luis Ferreiro et al.   CIRCULATION

Pyridoxine Improves Platelet Nitric Oxide Synthase Dysfunction Induced by Advanced Glycation End Products in vitro

(2011) Yi Han et al.   INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH

Hmgb1 Promotes Wound Healing of 3T3 Mouse Fibroblasts via Rage-Dependent ERK1/2 Activation

(2010) Elia Ranzato et al.   CELL BIOCHEMISTRY AND BIOPHYSICS

The RAGE Axis

(2010) Shi Fang Yan et al.   CIRCULATION RESEARCH

Oxidative Stress and Diabetic Complications

(2010) Ferdinando Giacco et al.   CIRCULATION RESEARCH

Review article: Platelet abnormalities in diabetes mellitus

(2010) José Luis Ferreiro et al.   Diabetes & Vascular Disease Research

CD36 participates in a signaling pathway that regulates ROS formation in murine VSMCs

(2010) Wei Li et al.   JOURNAL OF CLINICAL INVESTIGATION

Pigment epithelium-derived factor (PEDF) prevents platelet activation and aggregation in diabetic rats by blocking deleterious effects of advanced glycation end products (AGEs)

(2009) Sho-Ichi Yamagishi et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

A Specific CD36-Dependent Signaling Pathway Is Required for Platelet Activation by Oxidized Low-Density Lipoprotein

(2008) Kan Chen et al.   CIRCULATION RESEARCH

The metabolic syndrome and the risk of arterial and venous thrombosis

(2007) Massimo Franchini et al.   THROMBOSIS RESEARCH